Dosimetric Comparison of the Helical Tomotherapy, Volumetric-modulated Arc Therapy and Fixed-field Intensity-modulated Radiotherapy for Stage IIB-IIIB Non-small Cell Lung Cancer

Overview

Journal Sci Rep

Specialty Science

Date 2017 Nov 3

PMID 29093491

Citations 9

Authors

Yujin Xu

Weiye Deng

Shuangyan Yang

Pu Li

Yue Kong

Ye Tian

Zhongxing Liao

Ming Chen

Affiliations

Soon will be listed here.

Abstract

The study aimed to compare the dosimetric parameters to target dose coverage and the critical structures in the treatment planning of helical tomotherapy (TOMO), volumetric-modulated arc therapy (VMAT), and fixed-field intensity-modulated radiotherapy (IMRT) for NSCLC delivering conventionally fractionated radiotherapy. Thirty patients with pathologically confirmed NSCLC were included. Three radiation treatment plans were designed for each patient. All patients received the uniform prescription dose of 60 Gy to the planning target volume. The conformity index (CI), heterogeneity index (HI), and parameters of critical structures were calculated. A significantly superior mean CI was observed in VMAT than in TOMO or IMRT (P = 0.013, 0.001). Mean HI was also better using VAMT or IMRT than TOMO (P = 0.002, 0.003). Mean lung V and V were significantly reduced by TOMO compared to IMRT (P = 0.019, 0.029). The heart was spared by IMRT compared to TOMO in terms of mean heart dose, V, V, and V (P < 0.05). In larger tumor, VMAT provided the optimal dose distribution and sparing to heart. Compared to TOMO and IMRT, VMAT achieved better target dose distribution and similar sparing of critical structures. VMAT seemed to be the optimal technique for NSCLC.

Citing Articles

Investigation of the Effect of Calibration Curves Obtained from Different Computed Tomography Devices on the Dose Distribution of Tomotherapy Plans.

Demir H, Gul O, Kanyilmaz G J Med Phys. 2025; 49(4):545-550.

PMID: 39926133 PMC: 11801095. DOI: 10.4103/jmp.jmp_129_24.

Evaluation and Comparison of the Dose Received by the Mandible, Maxilla, and Teeth in Two Methods of Three-dimensional Conformal Radiation Therapy and Helical Tomotherapy.

Pourparvar Z, Shahbazi-Gahrouei D, Najafizade N, Saeb M, Moradi Khaniabadi B, Khaniabadi P J Med Signals Sens. 2024; 14:26.

PMID: 39380769 PMC: 11460734. DOI: 10.4103/jmss.jmss_42_23.

A deep learning-informed interpretation of why and when dose metrics outside the PTV can affect the risk of distant metastasis in SBRT NSCLC patients.

Dudas D, Dilling T, El Naqa I Radiat Oncol. 2024; 19(1):127.

PMID: 39334387 PMC: 11430131. DOI: 10.1186/s13014-024-02519-1.

Clinical and dosimetric predictors of radiation-induced rhinosinusitis following VMAT for nasopharyngeal carcinoma: A retrospective study.

Bao X, Wang Y, Li B, Peng L, Ouyang B, Ng C Heliyon. 2024; 10(1):e23554.

PMID: 38187301 PMC: 10770446. DOI: 10.1016/j.heliyon.2023.e23554.

Dosimetric comparison of four radiotherapy techniques for stage III non‑small cell lung cancer.

Li C, Luo H, Song W, Hu Y, Li J, Cai Z Oncol Lett. 2023; 26(2):347.

PMID: 37427336 PMC: 10326827. DOI: 10.3892/ol.2023.13933.

References

Xhaferllari I, El-Sherif O, Gaede S . Comprehensive dosimetric planning comparison for early-stage, non-small cell lung cancer with SABR: fixed-beam IMRT versus VMAT versus TomoTherapy. J Appl Clin Med Phys. 2016; 17(5):329-340. PMC: 5874107. DOI: 10.1120/jacmp.v17i5.6291. View

Otto K . Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys. 2008; 35(1):310-7. DOI: 10.1118/1.2818738. View

Zibold F, Sterzing F, Sroka-Perez G, Schubert K, Wagenknecht K, Major G . Surface dose in the treatment of breast cancer with helical tomotherapy. Strahlenther Onkol. 2009; 185(9):574-81. DOI: 10.1007/s00066-009-1979-7. View

Barriger R, Fakiris A, Hanna N, Yu M, Mantravadi P, McGarry R . Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel. Int J Radiat Oncol Biol Phys. 2010; 78(5):1381-6. DOI: 10.1016/j.ijrobp.2009.09.030. View

Liu H, Wang X, Dong L, Wu Q, Liao Z, Stevens C . Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004; 58(4):1268-79. DOI: 10.1016/j.ijrobp.2003.09.085. View

Tsujino K, Hashimoto T, Shimada T, Yoden E, Fujii O, Ota Y . Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer. J Thorac Oncol. 2014; 9(7):983-990. DOI: 10.1097/JTO.0000000000000187. View

Palma D, Verbakel W, Otto K, Senan S . New developments in arc radiation therapy: a review. Cancer Treat Rev. 2010; 36(5):393-9. DOI: 10.1016/j.ctrv.2010.01.004. View

Sterzing F, Schubert K, Sroka-Perez G, Kalz J, Debus J, Herfarth K . Helical tomotherapy. Experiences of the first 150 patients in Heidelberg. Strahlenther Onkol. 2008; 184(1):8-14. DOI: 10.1007/s00066-008-1778-6. View

Yom S, Liao Z, Liu H, Tucker S, Hu C, Wei X . Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2007; 68(1):94-102. DOI: 10.1016/j.ijrobp.2006.12.031. View

10.

Vanetti E, Clivio A, Nicolini G, Fogliata A, Ghosh-Laskar S, Agarwal J . Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT. Radiother Oncol. 2009; 92(1):111-7. DOI: 10.1016/j.radonc.2008.12.008. View

11.

Jacob V, Bayer W, Astner S, Busch R, Kneschaurek P . A planning comparison of dynamic IMRT for different collimator leaf thicknesses with helical tomotherapy and RapidArc for prostate and head and neck tumors. Strahlenther Onkol. 2010; 186(9):502-10. DOI: 10.1007/s00066-010-2124-3. View

12.

Liao Z, Komaki R, Thames Jr H, Liu H, Tucker S, Mohan R . Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2009; 76(3):775-81. DOI: 10.1016/j.ijrobp.2009.02.032. View

13.

Wiezorek T, Schwahofer A, Schubert K . The influence of different IMRT techniques on the peripheral dose: a comparison between sMLM-IMRT and helical tomotherapy. Strahlenther Onkol. 2009; 185(10):696-702. DOI: 10.1007/s00066-009-2005-9. View

14.

Zhu Z, Fu X . The radiation techniques of tomotherapy & intensity-modulated radiation therapy applied to lung cancer. Transl Lung Cancer Res. 2015; 4(3):265-74. PMC: 4483473. DOI: 10.3978/j.issn.2218-6751.2015.01.07. View

15.

Hsieh C, Chang H, Lin S, Chen Y, Wang L, Hsieh Y . Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment--case report. BMC Cancer. 2011; 10:696. PMC: 3022890. DOI: 10.1186/1471-2407-10-696. View

16.

Bertelsen A, Hansen C, Johansen J, Brink C . Single Arc Volumetric Modulated Arc Therapy of head and neck cancer. Radiother Oncol. 2010; 95(2):142-8. DOI: 10.1016/j.radonc.2010.01.011. View

17.

Giaddui T, Chen W, Yu J, Lin L, Simone 2nd C, Yuan L . Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC. Radiat Oncol. 2016; 11:66. PMC: 4855766. DOI: 10.1186/s13014-016-0640-8. View

18.

Wiezorek T, Brachwitz T, Georg D, Blank E, Fotina I, Habl G . Rotational IMRT techniques compared to fixed gantry IMRT and tomotherapy: multi-institutional planning study for head-and-neck cases. Radiat Oncol. 2011; 6:20. PMC: 3050734. DOI: 10.1186/1748-717X-6-20. View

19.

Kron T, Grigorov G, Yu E, Yartsev S, Chen J, Wong E . Planning evaluation of radiotherapy for complex lung cancer cases using helical tomotherapy. Phys Med Biol. 2004; 49(16):3675-90. DOI: 10.1088/0031-9155/49/16/014. View

20.

Bradley J, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S . Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two.... Lancet Oncol. 2015; 16(2):187-99. PMC: 4419359. DOI: 10.1016/S1470-2045(14)71207-0. View